PDCD1 and dermatomyositis: Although there are currently no specific intervention measures and recommendations to consider the effect of gender on the efficacy of PD-1 inhibitors in dermatomyositis, understanding the influence of gender differences on dermatomyositis is important for personalized treatment and optimizing therapeutic efficacy.